PDLIM2
PDZ and LIM domain protein 2
Also known as: PDLI2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96JY6
- Gene
- PDLIM2
- Ensembl
- ENSG00000120913
- Chromosome
- 8
- Canonical length
- 352 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Actin filaments,Focal adhesion sites
OverviewNCBI Gene
This gene encodes a member of the ALP subfamily of PDZ-LIM domain proteins. The encoded protein suppresses anchorage-dependent growth and promotes cell migration and adhesion through interactions with the actin cytoskeleton via the PDZ domain. The encoded protein is also a putative tumor suppressor protein, and decreased expression of this gene is associated with several malignancies including breast cancer and adult T-cell leukemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Oct 2011]
Canonical amino-acid sequenceUniProt
352 residues, UniProt reviewed canonical sequence.
>Q96JY6|PDLIM2
1 MALTVDVAGP APWGFRITGG RDFHTPIMVT KVAERGKAKD ADLRPGDIIV AINGESAEGM
61 LHAEAQSKIR QSPSPLRLQL DRSQATSPGQ TNGDSSLEVL ATRFQGSVRT YTESQSSLRS
121 SYSSPTSLSP RAGSPFSPPP SSSSLTGEAA ISRSFQSLAC SPGLPAADRL SYSGRPGSRQ
181 AGLGRAGDSA VLVLPPSPGP RSSRPSMDSE GGSLLLDEDS EVFKMLQENR EGRAAPRQSS
241 SFRLLQEALE AEERGGTPAF LPSSLSPQSS LPASRALATP PKLHTCEKCS TSIANQAVRI
301 QEGRYRHPGC YTCADCGLNL KMRGHFWVGD ELYCEKHARQ RYSAPATLSS RALocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDLIM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 224 nTPM
Expression across tissuesHPA
Tissue
- spleen: 224 nTPM
- skeletal muscle: 190 nTPM
- skin: 147 nTPM
- blood vessel: 133 nTPM
- esophagus: 123 nTPM
- cerebellum: 90 nTPM
Single-cell type
- enterocytes: 19 nCPM
- bergmann glia: 17 nCPM
- brain excitatory neurons: 13 nCPM
- alveolar cells type 1: 12 nCPM
- podocytes: 12 nCPM
- other brain neurons: 8.8 nCPM
Immune cell
- eosinophil: 159 nTPM
- neutrophil: 99 nTPM
- basophil: 76 nTPM
- non-classical monocyte: 61 nTPM
- intermediate monocyte: 60 nTPM
- memory CD8 T-cell: 47 nTPM
Brain region
- pons: 76 nTPM
- white matter: 65 nTPM
- midbrain: 64 nTPM
- medulla oblongata: 62 nTPM
- cerebellum: 58 nTPM
- thalamus: 58 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.09
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- heart development
- muscle structure development
- protein catabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PDLIM2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDLIM2 as an antibody target. Whether an autoantibody or antibody against PDLIM2 could matter depends on whether native PDLIM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDLIM2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PDLIM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...